|[January 15, 2013]
Wolters Kluwer Health, The Altos Group Highlight Long-Term Impact of Change Management on Sepsis Mortality Rates among California Hospital Cohort
MINNEAPOLIS --(Business Wire)--
Kluwer Health, a leading global provider of information for
healthcare professionals and students, announced today that nine
California hospitals have maintained a 50% sepsis mortality rate
reduction two years after participating in a change management study.
The company has integrated key elements of the study, which was designed
and led by its strategic partner, The Altos Group, into a
ground-breaking sepsis mortality reduction program.
As part of the California study, which was profiled
by the Agency for Healthcare Research and Quality (AHRQ), participating
hospitals adopted four common approaches: 1) sepsis screening of all
patients, 2) a fast-track workup to confirm the diagnosis, 3)
initiatives to promote adherence to protocols that call for prompt
initiation of appropriate treatment, and 4) ongoing monitoring. The
result was a 54.5% reduction in average mortality rates within three
years of the study's launch in December 2008.
In December 2012, all nine hospitals reported continued declines in
mortality rates. Additionally, the overall cohort-wide mortality rate
was down 49.8% relative to the baseline. The same change management
model was also studied for its impact on medication error rates. The
resulting 89% improvement was also maintained years after the active
phase of the program ended.
"These results demonstrate the validity of a change-management approach
to sepsis reduction," said Julie A. Kliger, MPA, BSN, president and CEO, The
Altos Group. "Equally important, these outcomes were maintained over
a significant period of time. That is vital in healthcare, where
sustaining improvement is as desired as it is elusive."
Wolters Kluwer Health's sepsis mortality reduction program focuses on
early detection and applying best practices to treating the septic
patient. In addition to reducing overall patient mortality, costs and
lengths of stay, the goal of the program is to identify and address the
top healthcare-associated infections (HAI) that drive sepsis mortality.
This will be accomplished through a three-pronged approach that couples
mobile software with actionable content supplemented by change
management consulting services. The program is driven by Wolters Kluwer
Health's trusted brands including UpToDate®,
Order Sets, and Sentri7®.
"Efficacy and sustainability are powerful motivators for clinicians who
are being asked to adopt new clinical practices and workflows.
Physicians want to make sure that the things they are being asked to do
actually improve patient care," said Linda R. Peitzman, M.D.,
Chief Medical Officer, Wolters Kluwer Health, Clinical Solutions.
"Though change management represents just one element of our sepsis
mortality reduction program, this demonstration of its long-term impact
is validation that an approach to disease management that looks at
multiple aspects of both the system and workflow is the right path to
Hospitals are currently being enrolled to serve as pilot sites in the
program. Interested facilities should contact Andy Strunk, Innovation
Lab Program Director, at (650) 224-4463 or firstname.lastname@example.org.
About Wolters Kluwer Health
Wolters Kluwer Health
(Philadelphia, PA) is a leading global provider of information, business
intelligence and point-of-care solutions for the healthcare industry.
Serving more than 150 countries and territories worldwide, Wolters
Kluwer Health's customers include professionals, institutions and
students in medicine, nursing, allied health and pharmacy. Major brands
include traditional publishers of medical and drug reference tools,
journals and textbooks, such as Lippincott
Williams & Wilkins; and electronic information providers, such
& Comparisons®, Pharmacy
Kluwer Health is part of Wolters
Kluwer, a market-leading global information services company.
Wolters Kluwer has 2011 annual revenues of €3.4 billion ($4.7 billion),
employs approximately 19,000 people worldwide, and maintains operations
in over 40 countries across Europe, North America, Asia Pacific, and
About The Altos Group
The Altos Group's mission is to
improve patient outcomes by creating highly trained, motivated and
engaged frontline practitioners. Our work has produced results that
directly correlate to a significant reduction in overall sepsis
mortality and medication errors. In addition to improved patient
outcomes and satisfaction, our clients have witnessed improved staff
satisfaction, retention, recruitment and professionalism.
The Altos Group works with healthcare providers to create programs that
are specifically designed to improve clinical, as well as operational,
outcomes. Our proven programs are results-oriented, creating a culture
of learning and accountability that translates into better patient
outcomes, a professionally fulfilled staff and improved financial
[ Back To IBM News 's Homepage ]